Thank you for your interest in the RetinAI Analysis Apps.

Please complete and submit the form here to access the app you have selected.

Once you have submitted the form you should be contacted within 1 working day.

Please note: The subscription is only valid for the trial period (soft launch) and we are granting access free of charge for the first 3 months, after this period license fees may apply.

The subscription will not be transferred to a paid subscription automatically you will have the option to stop using the service.



  • Our AI models for biomarkers, fluid and layer segmentation and quantification in retinal pathologies are CE-Marked medical devices according to the Medical Devices Directive 93/42/EEC. Our GA segmentation model is a tool for research use only in Europe.
  • Please be advised these tools are not intended to be a substitute for medical advice, diagnosis or treatment.
  • Please be advised that these tools are not intended to be a complete set of analyses for investigation of the disease area concerned.
  • You use the tools at your own risk. You must evaluate and take all responsibility associated with the use of any tool – we do not warrant any reliance on the accuracy, completeness or usefulness of any content.

RetinAI Analysis Apps.

via Heidelberg Appway.